share_log

ラクオリア創薬---続伸、胃酸分泌抑制剤tegoprazanがマレーシアで販売承認

Lear Pharmaceuticals---Continues to rise, gastric acid secretion inhibitor tegoprazan approved for sale in Malaysia.

Fisco Japan ·  Sep 26 20:26

Continued growth. It was announced that the gastric acid secretion inhibitor tegoprazan has obtained sales approval in Malaysia, and the purchase is ahead. Tegoprazan is a gastric acid secretion inhibitor with a new mechanism of action called a potassium-ion competitive acid blocker created by the company. The company holds the right to receive a portion of the profits HK Innoen Inc. obtains from partner companies based on a license agreement with HK Innoen, which is the derivation destination. There is no lump-sum payment that the company will receive this time, but it is said that they believe that expanding sales countries will contribute to improving business profits and corporate value over the medium to long term.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment